Sanofi to acquire vaccine maker Dynavax for USD 2.2 billion Ruchika Sharma24 Dec 2025 3:30 PM ISTParis: Sanofi has announced that it has entered into an agreement to acquire Dynavax Technologies Corporation, a publicly traded vaccines company...
Sanofi-Regeneron Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Ruchika Sharma23 Dec 2025 11:30 AM ISTParis: Sanofi and Regeneron have announced that the Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing...
Sanofi efdoralprin alfa earns orphan designation in EU for alpha-1 antitrypsin deficiency related emphysema Ruchika Sharma21 Dec 2025 12:30 PM ISTParis: Sanofi has announced that the European Medicines Agency (EMA) has granted orphan designation to efdoralprin alfa (SAR447537, formerly known as...
Sanofi gets approval for 2 rare hematologic diseases medicines in China Ruchika Sharma14 Dec 2025 11:30 AM ISTThese two approvals expand Sanofi's rare hematology portfolio in China.
Sanofi concludes acquisition of Vicebio Ruchika Sharma7 Dec 2025 4:00 PM ISTParis: French multinational pharmaceutical giant, Sanofi, has announced the completion of its acquisition of Vicebio Ltd.This acquisition brings...
Sanofi-Regeneron Dupixent approved in EU for chronic spontaneous urticaria Ruchika Sharma26 Nov 2025 1:00 PM ISTParis: Sanofi has announced that the European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic...
Sanofi Teizeild recommended for EU approval by CHMP for stage 2 type 1 diabetes Ruchika Sharma16 Nov 2025 12:30 PM ISTParis: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) has adopted a...
CDSCO Panel Recommends Updating Prescribing Information for Sanofi's Vaccine Susmita Roy28 Sept 2025 1:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended updation of the...
Sanofi India appoints Haresh Vala as Company Secretary, Compliance Officer Ruchika Sharma26 Sept 2025 2:00 PM ISTMumbai: Sanofi India has announced the appointment of Haresh Vala as the new Company Secretary and Compliance Officer of the Company, effective...
Sanofi Commits USD 625 Million to Sanofi Ventures to Boost Biotech and Digital Health Startups Farhat Nasim25 Sept 2025 3:45 PM ISTNew Delhi: Sanofi Ventures has announced a new USD 625 million multiyear capital commitment from Sanofi, increasing its total assets under management...
Sanofi SAR446268 wins USFDA fast track designation for non-congenital myotonic dystrophy type 1 Ruchika Sharma24 Sept 2025 1:45 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted fast track designation to SAR446268, Sanofi's one-time AAV...
Sanofi Tolebrutinib faces USFDA review delay; new target action date set for December 28 Ruchika Sharma22 Sept 2025 5:09 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has extended by three months the target action date of its review of...
